FOLD FY 2013 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$363,000-98.0% YoY

Gross Profit

-$13M-3616.8% margin

Operating Income

-$64M-17680.7% margin

Net Income

-$60M-16427.8% margin

EPS (Diluted)

$-1.16

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$128M

Total Liabilities

$82M

Stockholders' Equity

$46M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$363,000	$18M	-98.0%
Gross Profit	-$13M	-$2M	-567.8%
Operating Income	-$64M	-$53M	-21.3%
Net Income	-$60M	-$49M	-22.2%